NCT06890598
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06890598
Title Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer (SUNRAY-02)
Acronym SUNRAY-02
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Eli Lilly and Company
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | TUR | SWE | SVK | ROU | POL | NOR | NLD | ITA | ISR | HUN | GRC | GBR | FRA | ESP | DEU | CZE | CHE | BRA | BEL | AUT | AUS